E-cigarettes showed considerable promise as a smoking-cessation aid during a study in the U.K. that was recently published by Reed Wellbeing.
The health and lifestyle service engaged in a one-year pilot from February 2019 to February 2020 to independently assess the impact of directly supplying e-cigarettes as a form of nicotine replacement therapy (NRT) to up to 200 participants though the One You Haringey stop-smoking service.
Participants were given a choice between NRT, e-cigarettes or Champix. Those selecting e-cigarettes were provided with a device and pods free of charge and were supported to quit in line with treatment guidelines from the U.K. National Centre for Smoking Cessation and Training.
E-cigarettes outperformed both NRT and Champix in first-attempt quits during the trial. The devices achieved a 93 quit rate when used alone and a 72 percent quit rate when combined with NRT. NRT use resulted in a 49 percent quit rate and Champix achieved a quit rate of 57 percent.
Twelve weeks after the trail, 100 percent of e-cigarette users were still refraining from smoking, compared with 96 percent of participants who used e-cigarettes and NRT, 84 percent of those who used NRT and 91 percent of Champix users.